S D Katz

Summary

Affiliation: Yale University
Country: USA

Publications

  1. ncbi Peripheral limitations of maximal aerobic capacity in patients with chronic heart failure
    Stuart D Katz
    Yale University School of Medicine, Section of Cardiovascular Medicine, Heart Failure Center, New Haven, Conn 06510, USA
    J Nucl Cardiol 9:215-25. 2002
  2. ncbi Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure
    Stuart D Katz
    Department of Internal Medicine, Yale University School of Medicine, 135 College St, Ste 301, New Haven, CT 06510, USA
    Circulation 111:310-4. 2005
  3. ncbi Mechanisms and treatment of anemia in chronic heart failure
    Stuart D Katz
    Yale University School of Medicine, 135 College Street, Suite 301, New Haven, CT 06510, USA
    Congest Heart Fail 10:243-7. 2004
  4. ncbi Efficacy and safety of sildenafil citrate in men with erectile dysfunction and chronic heart failure
    Stuart D Katz
    Department of Internal Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut 06510, USA
    Am J Cardiol 95:36-42. 2005
  5. ncbi Potential role of type 5 phosphodiesterase inhibition in the treatment of congestive heart failure
    S D Katz
    Yale University School of Medicine, Heart Failure Center, Yale University, 135 College Street, Suite 201, New Haven, CT 06510, USA
    Congest Heart Fail 9:9-15. 2003
  6. ncbi Blood volume assessment in the diagnosis and treatment of chronic heart failure
    Stuart D Katz
    Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut 06510, USA
    Am J Med Sci 334:47-52. 2007
  7. ncbi Potential role of statins in the treatment of heart failure
    Stuart D Katz
    Yale Heart Failure and Transplant Center, Yale University School of Medicine, New Haven, CT, USA
    Curr Atheroscler Rep 10:318-23. 2008
  8. ncbi Comparison of metabolic vasodilation in response to exercise and ischemia and endothelium-dependent flow-mediated dilation in African-American versus non-African-American patients with chronic heart failure
    Ana Silvia Androne
    Department of Internal Medicine, Yale University College of Medicine, New Haven, Connecticut, USA
    Am J Cardiol 97:685-9. 2006
  9. ncbi Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects
    H Zheng
    Department of Medicine, Yale University School of Medicine, New Haven, Conneticut 06510, USA
    Kidney Int 69:679-84. 2006
  10. ncbi Inhibition of angiotensin-converting enzyme and phosphodiesterase type 5 improves endothelial function in heart failure
    Katarzyna Hryniewicz
    Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT 06510, U.S.A
    Clin Sci (Lond) 108:331-8. 2005

Research Grants

  1. Studies on Genetics in Heart Failure
    Stuart Katz; Fiscal Year: 2007

Collaborators

  • Ritchard G Cable
  • Donna Mancini
  • Alan J Bank
  • Hao Wang
  • John D Parker
  • X Huang
  • Sumit Verma
  • Ulrich P Jorde
  • Paolo C Colombo
  • M Packer
  • Chim C Lang
  • L Lund
  • Mathew S Maurer
  • Shunichi Homma
  • Katarzyna Hryniewicz
  • Haoyi Zheng
  • Ana Silvia Androne
  • Alhakam Hudaihed
  • Yi da Tang
  • Yi-Da Tang
  • Clarito Dimayuga
  • Dmitry Abramov
  • Milan Patel
  • H Zheng
  • Milan D Patel
  • Marc Klapholz
  • Clara Saldarriaga
  • Shrikanth P Y Upadya
  • Forrester A Lee
  • Artyom Sedrakyan
  • Shrikanth Upadya
  • Karin Nystrom
  • John Lamanca
  • A S Androne
  • Timothy J Vittorio
  • Ana-Silvia Androne
  • Rose S Cohen
  • Lawrence Young
  • Henry M Rinder
  • Aleksandr Yasskiy
  • Q Zhang
  • Ghazanfar Qureshi
  • Krzysztof Jankowski
  • Bryan Spencer
  • Nancy Votto
  • Frank Messineo
  • Khashayar Sehhat
  • Anita Soni
  • Thierry H Le Jemtel
  • Janis Bozzo
  • Robert Berkowitz
  • Nikita Varshneya
  • Robert A Phillips
  • Marrick Kukin
  • April M Lowe
  • Rachel Bijou
  • Richard Steingart
  • Edward J Brown
  • Jill Kalman
  • Judith Mitchell
  • Robert Moskowitz
  • Lynn A Sleeper
  • Jay S Meisner
  • K Hryniewicz
  • A Arwady
  • R Goldsmith

Detail Information

Publications33

  1. ncbi Peripheral limitations of maximal aerobic capacity in patients with chronic heart failure
    Stuart D Katz
    Yale University School of Medicine, Section of Cardiovascular Medicine, Heart Failure Center, New Haven, Conn 06510, USA
    J Nucl Cardiol 9:215-25. 2002
  2. ncbi Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure
    Stuart D Katz
    Department of Internal Medicine, Yale University School of Medicine, 135 College St, Ste 301, New Haven, CT 06510, USA
    Circulation 111:310-4. 2005
    ..Endothelial function is known to be impaired in subjects with chronic heart failure (CHF), but the association between endothelial function and subsequent mortality risk in CHF has not been previously reported...
  3. ncbi Mechanisms and treatment of anemia in chronic heart failure
    Stuart D Katz
    Yale University School of Medicine, 135 College Street, Suite 301, New Haven, CT 06510, USA
    Congest Heart Fail 10:243-7. 2004
    ..Additional studies are needed to determine the safety and efficacy of long-term erythropoietic therapy in chronic HF patients...
  4. ncbi Efficacy and safety of sildenafil citrate in men with erectile dysfunction and chronic heart failure
    Stuart D Katz
    Department of Internal Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut 06510, USA
    Am J Cardiol 95:36-42. 2005
    ..The incidence of events related to cardiovascular effects was low. Sildenafil is an effective and well-tolerated management of ED in men who have mild to moderate CHF...
  5. ncbi Potential role of type 5 phosphodiesterase inhibition in the treatment of congestive heart failure
    S D Katz
    Yale University School of Medicine, Heart Failure Center, Yale University, 135 College Street, Suite 201, New Haven, CT 06510, USA
    Congest Heart Fail 9:9-15. 2003
    ..Further studies are warranted to characterize the safety and efficacy of type 5 phosphodiesterase inhibition in the treatment of chronic heart failure...
  6. ncbi Blood volume assessment in the diagnosis and treatment of chronic heart failure
    Stuart D Katz
    Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut 06510, USA
    Am J Med Sci 334:47-52. 2007
    ..Additional work is needed to determine the clinical utility of serial blood volume measurements in the management of patients with CHF...
  7. ncbi Potential role of statins in the treatment of heart failure
    Stuart D Katz
    Yale Heart Failure and Transplant Center, Yale University School of Medicine, New Haven, CT, USA
    Curr Atheroscler Rep 10:318-23. 2008
    ..Until further information becomes available, routine use of statins is not recommended in the heart failure population...
  8. ncbi Comparison of metabolic vasodilation in response to exercise and ischemia and endothelium-dependent flow-mediated dilation in African-American versus non-African-American patients with chronic heart failure
    Ana Silvia Androne
    Department of Internal Medicine, Yale University College of Medicine, New Haven, Connecticut, USA
    Am J Cardiol 97:685-9. 2006
    ..Impaired vasodilation may contribute to differences in therapeutic response and clinical outcomes in African-American patients with chronic HF...
  9. ncbi Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects
    H Zheng
    Department of Medicine, Yale University School of Medicine, New Haven, Conneticut 06510, USA
    Kidney Int 69:679-84. 2006
    ..This potential mechanistic link between intravenous iron and endothelial dysfunction warrants further study of cardiovascular effects of intravenous iron in anemic chronic kidney disease populations...
  10. ncbi Inhibition of angiotensin-converting enzyme and phosphodiesterase type 5 improves endothelial function in heart failure
    Katarzyna Hryniewicz
    Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT 06510, U.S.A
    Clin Sci (Lond) 108:331-8. 2005
    ..Therefore further work to characterize chronic effects of combined ACE and PDE5 inhibition on endothelial function are warranted...
  11. ncbi Iron stores and vascular function in voluntary blood donors
    Haoyi Zheng
    Department of Internal Medicine, Yale University School of Medicine, 135 College St, Suite 301, New Haven, CT 06510, USA
    Arterioscler Thromb Vasc Biol 25:1577-83. 2005
    ..These findings support a potential link between blood donation and reduced cardiovascular risk that warrants further investigation in prospective outcome studies...
  12. ncbi Phosphodiesterase 5 inhibition in chronic heart failure and pulmonary hypertension
    Milan D Patel
    Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut 06510, USA
    Am J Cardiol 96:47M-51M. 2005
    ..Additional studies are needed to determine the therapeutic potential of this class of agents in these disease states...
  13. ncbi Acetylcholinesterase inhibition with pyridostigmine improves heart rate recovery after maximal exercise in patients with chronic heart failure
    A S Androne
    Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA
    Heart 89:854-8. 2003
    ..A specific effect of pyridostigmine on heart rate one minute after exercise suggests that pyridostigmine augments parasympathetic tone in patients with CHF...
  14. ncbi Relation of unrecognized hypervolemia in chronic heart failure to clinical status, hemodynamics, and patient outcomes
    Ana Silvia Androne
    Department of Internal Medicine, Yale University School of Medicine, 135 College Street, New Haven, CT 06510, USA
    Am J Cardiol 93:1254-9. 2004
    ..13 to 6.19, p = 0.025). These findings demonstrate that clinically unrecognized hypervolemia is frequently present in nonedematous patients with CHF and is associated with increased cardiac filling pressures and worse patient outcomes...
  15. ncbi Partial reversal of cachexia by beta-adrenergic receptor blocker therapy in patients with chronic heart failure
    Katarzyna Hryniewicz
    Department of Internal Medicine, Yale University College of Medicine, New Haven, Connecticut 06510, USA
    J Card Fail 9:464-8. 2003
    ..Further work is needed to determine the role the sympathetic nervous system in the pathogenesis of cachexia in patients with CHF...
  16. ncbi Treatment of anemia in patients with chronic heart failure
    Stuart D Katz
    Department of Internal Medicine, Yale University College of Medicine, New Haven, CT 06510, USA
    J Card Fail 10:S13-6. 2004
    ..Additional studies are needed to determine the safety and efficacy of long-term erythropoietic therapy in CHF patients...
  17. ncbi The prevalence of anemia in chronic heart failure and its impact on the clinical outcomes
    Yi da Tang
    Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT 06510, USA
    Heart Fail Rev 13:387-92. 2008
    ..These data provide the rationale for interventional treatment trials to determine if anemia is in the causal pathway for disease progression and increased mortality risk in HF patients...
  18. ncbi Effects of recombinant human erythropoietin on antiplatelet action of aspirin and clopidogrel in healthy subjects: results of a double-blind, placebo-controlled randomized trial
    Yi da Tang
    Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT 06510, USA
    Am Heart J 154:494.e1-7. 2007
    ..Whether prothrombotic effects of rHuEpo mitigate the effects of antiplatelet agents used in acute coronary syndrome patients is unknown...
  19. ncbi Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options
    Yi-Da Tang
    Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06510, USA
    Circulation 113:2454-61. 2006
  20. ncbi Insulin sensitivity, vascular function, and iron stores in voluntary blood donors
    Haoyi Zheng
    Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, 135 College St, New Haven, CT 06510, USA
    Diabetes Care 30:2685-9. 2007
    ..We sought to determine whether iron-dependent changes in glucose metabolism may contribute to improved vascular function in blood donors...
  21. ncbi Comparative costs of home positive inotropic infusion versus in-hospital care in patients awaiting cardiac transplantation
    Shrikanth P Y Upadya
    Yale University School of Medicine, Department of Internal Medicine, Section of Cardiovascular Medicine, New Haven, Connecticut 06510, USA
    J Card Fail 10:384-9. 2004
    ..CONCLUSION: Outpatient inotropic therapy combined with AICD implantation in selected patients awaiting cardiac transplantation is an effective cost-minimizing strategy...
  22. ncbi Home continuous positive inotropic infusion as a bridge to cardiac transplantation in patients with end-stage heart failure
    Shrikanth Upadya
    Yale University School of Medicine, Department of Internal Medicine, New Haven, Connecticut 06510, USA
    J Heart Lung Transplant 23:466-72. 2004
    ..CONCLUSIONS: Continuous positive inotropic therapy at home was safe and was associated with decreased health care costs in selected patients awaiting cardiac transplantation...
  23. ncbi Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure
    Ulrich P Jorde
    Division of Cardiology, New York University School of Medicine, New York, New York, USA
    Am J Cardiol 94:1501-5. 2004
    ....
  24. ncbi Effect of dexrazoxane on homocysteine-induced endothelial dysfunction in normal subjects
    Haoyi Zheng
    Department of Medicine, Peking Union Medical College Hospital, Beijing, China
    Arterioscler Thromb Vasc Biol 22:E15-8. 2002
    ..CONCLUSIONS: Administration of the novel antioxidant agent dexrazoxane prevents homocysteine-induced impairment of vascular endothelial function in the brachial artery of healthy subjects...
  25. ncbi Elevated plasma aldosterone levels despite complete inhibition of the vascular angiotensin-converting enzyme in chronic heart failure
    Ulrich P Jorde
    Division of Circulatory Physiology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA
    Circulation 106:1055-7. 2002
    ..Complete inhibition of the vascular converting enzyme does not obviate the need for aldosterone receptor blockade in patients with CHF...
  26. ncbi Hemodilution is common in patients with advanced heart failure
    Ana-Silvia Androne
    Department of Medicine, Columbia University, New York, NY, USA
    Circulation 107:226-9. 2003
    ..Patients with hemodilution tend to do worse than patients with true anemia, which suggests that volume overload may be an important mechanism contributing to the poor outcome in anemic CHF patients...
  27. ncbi Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure
    Donna M Mancini
    Department of Medicine, Columbia Presbyterian Medical Center, New York, NY, USA
    Circulation 107:294-9. 2003
    ..An increase in hemoglobin could enhance exercise performance by increasing oxygen delivery. We investigated the effect of erythropoietin (EPO) on exercise performance in anemic patients with CHF...
  28. ncbi Association of extended work shifts, vascular function, and inflammatory markers in internal medicine residents: a randomized crossover trial
    Haoyi Zheng
    JAMA 296:1049-50. 2006
  29. ncbi Dissociation between exercise hemodynamics and exercise capacity in patients with chronic heart failure and marked increase in ejection fraction after treatment with beta-adrenergic receptor antagonists
    Mathew Maurer
    Division of Circulatory Physiology, Columbia Presbyterian Medical Center, New York, New York, USA
    Am J Cardiol 91:356-60. 2003
  30. ncbi Comparative effects of carvedilol and metoprolol on regional vascular responses to adrenergic stimuli in normal subjects and patients with chronic heart failure
    Katarzyna Hryniewicz
    Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA
    Circulation 108:971-6. 2003
    ..These data suggest that long-term benefits of carvedilol in heart failure are not mediated by alpha-adrenergic blockade...
  31. ncbi Vasopressor response to angiotensin II infusion in patients with chronic heart failure receiving beta-blockers
    Timothy J Vittorio
    Division of Circulatory Physiology, Columbia Presbyterian Medical Center, New York, NY 10032, USA
    Circulation 107:290-3. 2003
    ..Whether this is due to the alpha1-adrenergic blocking or other ancillary properties of carvedilol warrants further investigation...
  32. ncbi Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry
    Marc Klapholz
    Saint Vincent Catholic Medical Centers, New York, New York, USA
    J Am Coll Cardiol 43:1432-8. 2004
    ..2%. CONCLUSIONS: Patients hospitalized for HFNEF are most often chronically incapacitated elderly women with a history of hypertension and increased LV mass. Reasons for clinical decompensation are identified in only one-half of patients...
  33. ncbi Comparison of blood volume characteristics in anemic patients with low versus preserved left ventricular ejection fractions
    Dmitry Abramov
    Columbia University Medical Center, New York, New York, USA
    Am J Cardiol 102:1069-72. 2008
    ....

Research Grants1

  1. Studies on Genetics in Heart Failure
    Stuart Katz; Fiscal Year: 2007
    ..The proposed studies will advance applicant career development and provide new insight into pathophysiology of CHF. ..